Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function: The PROTECT IV Trial

NCT04763200 is registered in ClinicalTrials.gov with Abiomed Inc. as lead sponsor.

NCT NCT04763200
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04763200 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function: The PROTECT IV Trial
Lead sponsor
Abiomed Inc.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
April 13, 2021
Completion date
October 31, 2027
Enrollment
1,252 (estimated)
Sites
110

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, left ventricular dysfunction